Growth Metrics

Tvardi Therapeutics (TVRD) Accounts Payables: 2013-2015

Historic Accounts Payables for Tvardi Therapeutics (TVRD) over the last 3 years, with Dec 2015 value amounting to $5.3 million.

  • Tvardi Therapeutics' Accounts Payables rose 170.71% to $5.3 million in Q4 2015 from the same period last year, while for Dec 2015 it was $5.3 million, marking a year-over-year increase of 170.71%. This contributed to the annual value of $5.3 million for FY2015, which is 170.71% up from last year.
  • Tvardi Therapeutics' Accounts Payables amounted to $5.3 million in FY2015, which was up 170.71% from $1.9 million recorded in FY2014.
  • Over the past 5 years, Tvardi Therapeutics' Accounts Payables peaked at $5.3 million during FY2015, and registered a low of $1.9 million during FY2014.
  • For the 3-year period, Tvardi Therapeutics' Accounts Payables averaged around $3.1 million, with its median value being $2.0 million (2013).
  • In the last 5 years, Tvardi Therapeutics' Accounts Payables declined by 0.61% in 2014 and then surged by 170.71% in 2015.
  • Yearly analysis of 3 years shows Tvardi Therapeutics' Accounts Payables stood at $2.0 million in 2013, then fell by 0.61% to $1.9 million in 2014, then surged by 170.71% to $5.3 million in 2015.